Related Experiment Video
Updated: Feb 8, 2026

Microelectrode Impalement Method to Record Membrane Potential from a Cannulated Middle Cerebral Artery
Published on: July 2, 2019
Potential Role of Antihypertensive Medications in Preventing Excessive Arterial Stiffening
Guanghong Jia1,2, Annayya R Aroor3,4, Luis A Martinez-Lemus4,5,6
1Diabetes and Cardiovascular Research Center, University of Missouri School of Medicine, D109 Diabetes Center HSC, One Hospital Drive, Columbia, MO, 65212, USA. jiag@health.missouri.edu.
Insights
Arterial stiffness, a precursor to cardiovascular disease, involves vascular wall changes. This review explores causes of arterial stiffening and therapies to manage vascular fibrosis and stiffness.
Area of Science:
- Cardiovascular Medicine
- Vascular Biology
- Hypertension Research
Background:
- Increased arterial stiffness is an abnormal vascular wall change, preceding hypertension and cardiovascular disease (CVD).
- Arterial stiffness is an independent predictor of CVD morbidity and mortality, as shown by the Framingham Heart Study.
- Pathophysiology involves endothelial and smooth muscle cell dysfunction, extracellular matrix changes, and other vessel wall elements.
Purpose of the Study:
- To review the etiology of arterial stiffening.
- To explore potential therapeutic strategies for modulating arterial fibrosis and stiffness.
Main Methods:
- Literature review of studies on arterial stiffness.
- Analysis of mechanisms contributing to vascular fibrosis and stiffening.
- Examination of therapeutic targets for arterial stiffness.
Main Results:
- Factors contributing to arterial stiffness include an activated renin-angiotensin-aldosterone system, oxidative stress, inflammation, and sympathetic nervous system activity.
- These factors promote arterial fibrosis and stiffening, increasing CVD risk.
- Structural and functional changes in the vessel wall are central to arterial stiffness.
Conclusions:
- Understanding the mechanisms of arterial stiffening is crucial for developing effective CVD prevention strategies.
- Therapeutic approaches targeting fibrosis and stiffness may offer new avenues for managing hypertension and associated cardiovascular risks.
Purpose Of Review:
Increased arterial stiffness, an abnormal structural and functional change in the vascular wall, is a precursor for hypertension, coronary heart disease, stroke, and associated cardiovascular disease (CVD). The aim of this paper is to review the etiology of arterial stiffening and potential therapeutic approaches to modulate arterial fibrosis and stiffness.
Recent Findings:
The Framingham Heart Study demonstrated that arterial stiffness is an independent predictor of CVD and related morbidity and mortality. Dysfunction of endothelial cells, vascular smooth muscle cells, extracellular matrix, and other functional elements of the vessel wall contribute to underlying pathophysiology of increased arterial stiffness. An activated renin-angiotensin-aldosterone system, oxidative stress, abnormal peri-vascular adipose tissue, inflammation, and increased sympathetic nervous system activity are associated with the development and progression of arterial fibrosis, stiffening, and associated CVD. In this review, we will discuss the structural and function changes and mechanisms of the vessel wall in arterial stiffness and provide potential therapeutic strategies.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Excess Pressure Inside a Drop and a Bubble
Antihypertensive Drugs: Vasodilators
Antihypertensive Drugs: Action of Diuretics
Cancer Prevention
Some...
Inhaled Medications

